A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
Clinical trial NCT06533553 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06533553
- Sponsor
- Areteia Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-09
- Primary completion
- 2025-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.